Dr. Peter T Ngo , MD
Specialist • Laredo, TX
1710 E Saunders St, Suite B350
Laredo, TX 780415443
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on March 29, 2006; this date does not establish years in practice.
-
Published CMS data list 341 Original Medicare Part B services in 2023.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023. Published rows only; this is not a quality measure.
-
Published Part B service records, 2023:
- 99214 — Established patient outpatient office visit: 140 service units.
- 99212 — Established patient outpatient office visit: 66 service units.
- 99213 — Established patient outpatient office visit: 48 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2022 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2023). CPT notice
See all 6 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 311 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Rosuvastatin Calcium — 49 prescription fills, including refills.
- Atorvastatin Calcium — 48 prescription fills, including refills.
- Levothyroxine Sodium — 39 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 15 records in the table · Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Part D prescriptions among clinicians listed under Specialist in Texas (2024, 367 clinicians with data). Median for this group: 458. Middle half: 89 to 1,434.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 805 in 2019 to 341 in 2023.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019–2023.
Practice Location & Contact Primary Location
1710 E Saunders St
Suite B350
Laredo, TX 780415443
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Specialist: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare-allowed amount
About $29,951 in 2023
The total amount Medicare approved for these services in 2023. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023.
Paid by Medicare
About $20,916 in 2023
The part of the Medicare-allowed amount that Medicare itself paid in 2023, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023.
30-day fills
790 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$79,869 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2023
All general payments: $640.45 across 37 records.
By nature of payment
- Food and Beverage: $640.45 across 37 records.
Reporting-company totals (3 largest of 11)
- Eli Lilly and Company: $175.79 across 10 records.
- Novo Nordisk Inc: $141.55 across 11 records.
- Xeris Pharmaceuticals, Inc.: $68.56 across 3 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2023 (published June 30, 2026).
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Ngo has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Ngo as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Laredo and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Specialist in Texas (2024, 367 clinicians with data). Median for this group: 458. Middle half: 89 to 1,434.
Too few clinicians listed under Specialist in Laredo have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 65% of clinicians listed under Specialist in Texas (2024, 367 clinicians with data). Median for this group: $19,718. Middle half: $1,229 to $181,992.
Too few clinicians listed under Specialist in Laredo have Medicare Part D data for 2024 to compare.
Medicare Part B
Comparisons use 2024 data. The latest CMS data for Dr. Ngo are from 2023.
8 active clinicians are listed under Specialist with a practice address in Laredo, TX (1,729 in Texas).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 58% from 805 in 2019 to 341 in 2023.
- 2019: 805
- 2020: 775
- 2021: 679
- 2022: 633
- 2023: 341
-
Medicare-allowed amount
Medicare-allowed amount decreased 59% from $72,592 in 2019 to $29,951 in 2023.
- 2019: $72,592
- 2020: $66,543
- 2021: $66,306
- 2022: $58,021
- 2023: $29,951
-
Paid by Medicare
Paid by Medicare decreased 61% from $54,076 in 2019 to $20,916 in 2023.
- 2019: $54,076
- 2020: $49,049
- 2021: $50,590
- 2022: $41,963
- 2023: $20,916
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 95% from 5,734 in 2020 to 311 in 2024.
- 2020: 5,734
- 2021: 5,390
- 2022: 5,363
- 2023: 4,903
- 2024: 311
-
30-day fills
30-day fills decreased 93% from 10,657 in 2020 to 790 in 2024.
- 2020: 10,657
- 2021: 10,276
- 2022: 9,878
- 2023: 9,527
- 2024: 790
-
Part D drug cost
Part D drug cost decreased 96% from $1,977,955 in 2020 to $79,869 in 2024.
- 2020: $1,977,955
- 2021: $1,878,948
- 2022: $1,991,295
- 2023: $2,224,903
- 2024: $79,869
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $831.76 in 2019 to $640.45 in 2023.
- 2019: $831.76
- 2020: $895.54
- 2021: $958.95
- 2022: $897.36
- 2023: $640.45
Sources: CMS Medicare Physician & Other Practitioners (2023), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2023), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2023 (payments made January 1 – December 31, 2023): 37 records totaling $640.45.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $28.25 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $26.80 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $24.72 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $24.21 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Rybelsus | General | $23.75 |
| Xeris Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
GVOKE HYPOPEN | General | $23.52 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SYNTHROID | General | $23.38 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $22.62 |
| Xeris Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
GVOKE HYPOPEN | General | $22.57 |
| Xeris Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
GVOKE HYPOPEN | General | $22.47 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
UBRELVY | General | $22.00 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Rybelsus | General | $21.43 |
| Corcept Therapeutics |
Food and Beverage
In-kind items and services
|
Korlym | General | $21.37 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $21.20 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $21.07 |
| Abbott Laboratories |
Food and Beverage
In-kind items and services
|
FREESTYLE LIBRE | General | $21.06 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $21.00 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
BAQSIMI | General | $20.94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $20.72 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
TOUJEO | General | $20.11 |
| Amryt Pharma Holdings Ltd |
Food and Beverage
In-kind items and services
|
MYCAPSSA | General | $19.81 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
UBRELVY | General | $19.66 |
| Corcept Therapeutics |
Food and Beverage
In-kind items and services
|
Korlym | General | $19.37 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $18.17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $16.99 |
(top 25 shown)
Source: CMS Open Payments, program year 2023, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2022 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2023; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
140 | 100 | $140.00 | $119.49 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
66 | 32 | $47.00 | $46.33 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
48 | 35 | $100.00 | $82.73 |
|
95251
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report
|
34 | 23 | $90.00 | $33.28 |
|
96372
Injection of drug or substance under skin or into muscle
|
31 | 11 | $60.00 | $13.53 |
|
99205
New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
|
22 | 22 | $400.00 | $211.04 |
Source: CMS Part B by Provider and Service, 2023; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 49 | 4,320 | $708.27 | 30 |
| Atorvastatin Calcium | Atorvastatin Calcium | 48 | 4,290 | $452.90 | 32 |
| Levothyroxine Sodium | Levothyroxine Sodium | 39 | 3,450 | $459.18 | 31 |
| Ozempic | Semaglutide | 20 | 1,018 | $33,121.54 | 12 |
| Ezetimibe | Ezetimibe | 18 | 1,560 | $230.88 | 15 |
| Glimepiride | Glimepiride | 17 | 1,490 | $111.71 | 11 |
| Synthroid | Levothyroxine Sodium | 16 | 1,020 | $1,598.35 | — |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 15 | 816 | $1,052.51 | — |
| Lisinopril | Lisinopril | 14 | 1,200 | $85.27 | 11 |
| Gabapentin | Gabapentin | 14 | 1,020 | $287.17 | — |
| Trulicity | Dulaglutide | 14 | 504 | $16,968.16 | — |
| Farxiga | Dapagliflozin Propanediol | 13 | 570 | $10,785.33 | — |
| Losartan Potassium | Losartan Potassium | 12 | 1,080 | $141.34 | — |
| Alendronate Sodium | Alendronate Sodium | 11 | 924 | $94.50 | — |
| Mounjaro | Tirzepatide | 11 | 366 | $13,772.28 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 174400000X
An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - ENDOCRINOLOGY
I20090224000540
TX
5597774042
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine
Doctor of Medicine (M.D.)
Nurse Practitioner - Family
Family Nurse Practitioner
Family Medicine - Adult Medicine
Doctor of Medicine (M.D.)
Internal Medicine - Cardiovascular Disease
Doctor of Medicine (M.D.)
Orthopaedic Surgery
Doctor of Medicine (M.D.)
Otolaryngology
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated March 29, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Specialists in Laredo
Healthcare providers in LaredoMailing Address
Po Box 3289
Laredo, TX 780443289
Phone: 9567129171